NSC697923
SIGMA/SML0618 - ≥98% (HPLC)
Synonym: 2-Nitro-5-tosylfuran; 2-
CAS Number: 343351-67-7
Empirical Formula (Hill Notation): C11H9NO5S
Molecular Weight: 267.26
Linear Formula: C11H9NO5S
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to beige |
| form | powder |
| InChI | 1S/C11H9NO5S/c1-8-2-4-9(5 |
| InChI key | GAUHIPWCDXOLCZ-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | [S](=O)(=O)(c2[o]c(cc2)[N |
| solubility | DMSO: 20 mg/mL, clear |
| storage temp. | −20°C |
| Application: | NSC697923 has been used as an inhibitor in STING-dependent NF-κB (nuclear factor-κB) activation after DNA damage, mediated by TRAF6 (TNF receptor-associated factor 6). |
| Biochem/physiol Actions: | NSC697923 is a cell-permeable and selective inhibitor of the ubiquitin-conjugating (E2) enzyme Ubc13-Uev1A that blocks the formation of the Ubc13 - ubiquitin thioester conjugate, and suppresses constitutive NF-kB activity in ABC-DLBCL cells. Also, NSC697923 inhibits the proliferation and survival of ABC-DLBCL and GCB-DLBCL cancer cells. |
| Biochem/physiol Actions: | NSC697923 is a cell-permeable and selective inhibitor of the ubiquitin-conjugating (E2) enzyme Ubc13-Uev1A. |
| General description: | NSC697923 stimulates apoptosis in p53 mutant neuroblastoma (NB) cells by triggering JNK (c-Jun N-terminal kinases) pathway. This ubiquitin-conjugating enzyme E2 N (UBE2N) inhibitor is considered as an important treatment option for neuroblastoma (NB) patients. NSC697923 prevents the multiplication and survival of diffuse large B-cell lymphoma (DLBCL) cells in vitro. |
| Packaging: | 5, 25 mg in glass bottle |
| Hazard Codes | Xn |
| Risk Statements | 22-41 |
| Safety Statements | 26-39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

